JP Morgan Chase & Co’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $21.9M | Sell |
|
|||||
|
2025
Q2 | $16.9M | Buy |
|
|||||
|
2025
Q1 | $9.28M | Sell |
|
|||||
|
2024
Q4 | $19.8M | Sell |
|
|||||
|
2024
Q3 | $15M | Buy |
|
|||||
|
2024
Q2 | $14.8M | Sell |
|
|||||
|
2024
Q1 | $14.8M | Sell |
|
|||||
|
2023
Q4 | $13.7M | Sell |
|
|||||
|
2023
Q3 | $14.4M | Buy |
|
|||||
|
2023
Q2 | $20.4M | Buy |
|
|||||
|
2023
Q1 | $12.9M | Sell |
|
|||||
|
2022
Q4 | $15.8M | Buy |
|
|||||
|
2022
Q3 | $2.36M | Sell |
|
|||||
|
2022
Q2 | $2.85M | Buy |
|
|||||
|
2022
Q1 | $3.5M | Buy |
|
|||||
|
2021
Q4 | $2.94M | Sell |
|
|||||
|
2021
Q3 | $2.87M | Buy |
|
|||||
|
2021
Q2 | $727K | Buy |
|
|||||
|
2021
Q1 | $637K | Buy |
|
|||||
|
2020
Q4 | $442K | Buy |
|
|||||
|
2020
Q3 | $389K | Buy |
|
|||||
|
2020
Q2 | $334K | Buy |
|
|||||
|
2020
Q1 | $195K | Buy |
|
|||||
|
2019
Q4 | $231K | Sell |
|
|||||
|
2019
Q3 | $221K | Buy |
|
|||||
|
2019
Q2 | $216K | Buy |
|
|||||
|
2019
Q1 | $211K | Sell |
|
|||||
|
2018
Q4 | $44M | Buy |
|
|||||
|
2018
Q3 | $365K | Sell |
|
|||||
|
2018
Q2 | $5.63M | Sell |
|
|||||
|
2018
Q1 | $4.09M | Buy |
|
|||||
|
2017
Q4 | $91K | Sell |
|
|||||
|
2017
Q3 | $325K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $45K | Buy |
|
|||||
|
2016
Q4 | $31K | Buy |
|
|||||
|
2016
Q3 | $1K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $9.22M | Sell |
|
|||||
|
2013
Q3 | $11.3M | Sell |
|
|||||
|
2013
Q2 | $9.21M | Buy |
|